Kam W. Leong

Active 1966–2026

294
Papers
51,895
Citations
130
h-index
273
i10-index

Citations

Citations per year for Kam W. Leong1973: 1 citations1978: 1 citations1983: 1 citations1984: 1 citations1985: 4 citations1986: 5 citations1987: 5 citations1988: 2 citations1989: 7 citations1990: 17 citations1991: 8 citations1992: 6 citations1993: 18 citations1994: 16 citations1995: 17 citations1996: 14 citations1997: 15 citations1998: 21 citations1999: 44 citations2000: 69 citations2001: 79 citations2002: 105 citations2003: 114 citations2004: 166 citations2005: 168 citations2006: 223 citations2007: 301 citations2008: 378 citations2009: 425 citations2010: 474 citations2011: 374 citations2012: 409 citations2013: 442 citations2014: 451 citations2015: 485 citations2016: 451 citations2017: 497 citations2018: 553 citations2019: 1,306 citations2020: 1,570 citations2021: 1,725 citations2022: 1,665 citations2023: 1,538 citations2024: 2,155 citations2025: 1,319 citations2026: 44 citations1974–1977: no citations, so these years are not shown1979–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 5,164 citing papers, 24.8% of this breakdownUnited States: 4,653 citing papers, 22.3% of this breakdownUnited Kingdom: 829 citing papers, 4% of this breakdownIndia: 813 citing papers, 3.9% of this breakdownSouth Korea: 754 citing papers, 3.6% of this breakdownGermany: 672 citing papers, 3.2% of this breakdownIran: 551 citing papers, 2.7% of this breakdownAustralia: 485 citing papers, 2.3% of this breakdownCanada: 481 citing papers, 2.3% of this breakdownSingapore: 461 citing papers, 2.2% of this breakdownItaly: 446 citing papers, 2.2% of this breakdownFrance: 380 citing papers, 1.8% of this breakdown
0%24.8%Other 24.7%

Fields

  • Biochemistry, Genetics and Molecular Biology33.2%
  • Medicine19.9%
  • Materials Science15.7%
  • Engineering15.5%
  • Pharmacology, Toxicology and Pharmaceutics4.3%
  • Immunology and Microbiology4.2%
  • Other7.2%

Topics

  • RNA Interference and Gene Delivery6%
  • Electrospun Nanofibers in Biomedical Applications4.4%
  • Advanced biosensing and bioanalysis techniques4.1%
  • 3D Printing in Biomedical Research3.6%
  • Nanoparticle-Based Drug Delivery3.5%
  • Nanoplatforms for cancer theranostics3%
  • Other75.4%

Coauthors

All papers

Open in search
  1. Spatial epigenome–transcriptome co-profiling of mammalian tissues

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature 2023 cited by 423

  2. Design of therapeutic biomaterials to control inflammation

    Authors: , , , , , , , , - Nature Reviews Materials 2022 cited by 494

  3. Advanced drug delivery systems and artificial skin grafts for skin wound healing

    Authors: , , , , , - Advanced Drug Delivery Reviews 2018 cited by 619

  4. Spatial profiling of chromatin accessibility in mouse and human tissues

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 357

  5. Scaffolding in tissue engineering: general approaches and tissue-specific considerations

    Authors: , - European Spine Journal 2008 cited by 1,680

  6. RNA-guided gene activation by CRISPR-Cas9–based transcription factors

    Authors: , , , , , , , , , , , , , - Nature Methods 2013 cited by 1,349

  7. A programmable encapsulation system improves delivery of therapeutic bacteria in mice

    Authors: , , , , , , , , , , , , , , , - Nature Biotechnology 2022 cited by 251

  8. Probiotic‐Inspired Nanomedicine Restores Intestinal Homeostasis in Colitis by Regulating Redox Balance, Immune Responses, and the Gut Microbiome

    Authors: , , , , , , , , , , - Advanced Materials 2022 cited by 173

  9. A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease

    Authors: , , , , , , , , , , , , , , , , , , - Science Advances 2022 cited by 222

  10. Diverse Applications of Nanomedicine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark C. Hersam, Patrick Hunziker, Jian Ji, Xingyu Jiang, Philipp Jungebluth, Pranav Kadhiresan, Kazunori Kataoka, Ali Khademhosseini, Jindŕich Kopec̆ek, Nicholas A. Kotov, Harald F. Krug, Dong Soo Lee, Claus‐Michael Lehr, Kam W. Leong, Xing‐Jie Liang, Mei Ling Lim, Luis M. Liz‐Marzán, Xiaowei Ma, Paolo Macchiarini, Huan Meng, Helmuth Möhwald, Paul Mulvaney, André E. Nel, Shuming Nie, Peter Nordlander, Teruo Okano, J.P.R. de Oliveira, Tai Hyun Park, Reginald M. Penner, Maurizio Prato, Víctor Puntes, Vincent M. Rotello, Amila Samarakoon, Raymond E. Schaak, Youqing Shen, Sebastian Sjöqvist, André G. Skirtach, Mahmoud G. Soliman, Molly M. Stevens, Hsing‐Wen Sung, Ben Zhong Tang, Rainer Tietze, Buddhisha Udugama, J. Scott VanEpps, Tanja Weil, Paul S. Weiss, Itamar Willner, Yuzhou Wu, Lily Yang, Zhao Yue, Qian Zhang, Qiang Zhang, Xian‐En Zhang, Yuliang Zhao, Xin Zhou, Wolfgang J. Parak - ACS Nano 2017 cited by 1,341

  11. Blood-brain barrier–penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy

    Authors: , , , , , , , , , , , , , , - Science Advances 2022 cited by 208

  12. Nanoparticulate cell-free DNA scavenger for treating inflammatory bone loss in periodontitis

    Authors: , , , , , , , , , , , , , , - Nature Communications 2022 cited by 135

  13. A DAMP-scavenging, IL-10-releasing hydrogel promotes neural regeneration and motor function recovery after spinal cord injury

    Authors: , , , , , , , , , - Biomaterials 2021 cited by 185

  14. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery

    Authors: , , , , , , - Chemical Reviews 2017 cited by 556

  15. Challenges and opportunities for the next generation of cardiovascular tissue engineering

    Authors: , , , , - Nature Methods 2022 cited by 165

  16. Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation

    Authors: , , , , , - Advanced Science 2019 cited by 237

  17. Light: A Magical Tool for Controlled Drug Delivery

    Authors: , , , , - Advanced Functional Materials 2020 cited by 304

  18. Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation

    Authors: , , , , , , , , , , , , - Nature Communications 2018 cited by 211

  19. Bacterial therapies at the interface of synthetic biology and nanomedicine

    Authors: , , , , , - Nature Reviews Bioengineering 2023 cited by 106

  20. Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers

    Authors: , , , , , , , , , , , , , , , , , - Science Advances 2020 cited by 182

  21. Engineered materials for in vivo delivery of genome-editing machinery

    Authors: , , , , - Nature Reviews Materials 2019 cited by 203

  22. Biomimetic Diselenide‐Bridged Mesoporous Organosilica Nanoparticles as an X‐ray‐Responsive Biodegradable Carrier for Chemo‐Immunotherapy

    Authors: , , , , , , , , , , , , , , - Advanced Materials 2020 cited by 234

  23. Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects

    Authors: , , , , , , , - Science Advances 2020 cited by 163

  24. 3D Printing of Highly Stretchable and Tough Hydrogels into Complex, Cellularized Structures

    Authors: , , , , , , , - Advanced Materials 2015 cited by 868